Increasing the number of glucose transporters in muscle ameliorates many of the symptoms associated with type 2 diabetes. This thesis identifies mechanisms regulating glucose transporter gene expression, and therefore glucose transporter number, in human skeletal muscle and provides potential targets for the treatment and management of type 2 diabetes
Notes
Submitted to the School of Exercise and Nutrition Sciences of the Faculty of Health and Behavioural Sciences, Deakin University